Skip to content
10-Q

Quarterly Report

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

0001193125-11-292827

← back to feed
Filed
Nov 2, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Oct 26, 2011 113.69M sh
Shares Diluted Q3 2011 · Sep 30, 2011 115.19M sh
Shares Diluted Q3 2011 · Sep 30, 2011 116.03M sh
Shares Diluted Q3 2011 · Sep 30, 2010 119.81M sh
Shares Diluted Q3 2011 · Sep 30, 2010 119.57M sh
Stock Repurchased Q3 2011 · Sep 30, 2011 $200M
Dividends Paid Q3 2011 · Sep 30, 2011 $52.82M
Dividends Paid Q3 2011 · Sep 30, 2010 $53.42M
Capex Q3 2011 · Sep 30, 2011 $61.7M
Capex Q3 2011 · Sep 30, 2010 $41.3M
Operating Cash Flow Q3 2011 · Sep 30, 2011 $150.74M
Operating Cash Flow Q3 2011 · Sep 30, 2010 $169.37M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $416.75M
Cash And Equivalents Q3 2011 · Dec 31, 2010 $479.57M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $440.44M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $408.9M
Stockholders Equity Q3 2011 · Sep 30, 2011 $1.19B
Stockholders Equity Q3 2011 · Dec 31, 2010 $1.28B
Current Liabilities Q3 2011 · Sep 30, 2011 $651.28M
Current Liabilities Q3 2011 · Dec 31, 2010 $613.71M
Total Liabilities Q3 2011 · Sep 30, 2011 $750.25M
Total Liabilities Q3 2011 · Dec 31, 2010 $701.38M
Current Assets Q3 2011 · Sep 30, 2011 $1.1B
Current Assets Q3 2011 · Dec 31, 2010 $1.13B
Total Assets Q3 2011 · Sep 30, 2011 $1.95B
Total Assets Q3 2011 · Dec 31, 2010 $1.99B
Eps Diluted Q3 2011 · Sep 30, 2011 $0.31
Eps Diluted Q3 2011 · Sep 30, 2011 $1.03
Eps Diluted Q3 2011 · Sep 30, 2010 $0.32
Eps Diluted Q3 2011 · Sep 30, 2010 $0.64
Eps Basic Q3 2011 · Sep 30, 2011 $0.31
Eps Basic Q3 2011 · Sep 30, 2011 $1.04
Eps Basic Q3 2011 · Sep 30, 2010 $0.32
Eps Basic Q3 2011 · Sep 30, 2010 $0.64
Sga Expense Q3 2011 · Sep 30, 2011 $107.58M
Sga Expense Q3 2011 · Sep 30, 2011 $322.98M
Sga Expense Q3 2011 · Sep 30, 2010 $102.37M
Sga Expense Q3 2011 · Sep 30, 2010 $327.38M
Rd Expense Q3 2011 · Sep 30, 2011 $2.07M
Rd Expense Q3 2011 · Sep 30, 2011 $6.08M
Rd Expense Q3 2011 · Sep 30, 2010 $470K
Rd Expense Q3 2011 · Sep 30, 2010 $15.25M
Net Income Q3 2011 · Sep 30, 2011 $35.62M
Net Income Q3 2011 · Sep 30, 2011 $118.4M
Net Income Q3 2011 · Sep 30, 2010 $38M
Net Income Q3 2011 · Sep 30, 2010 $76.18M
Operating Income Q3 2011 · Sep 30, 2011 $65.42M
Operating Income Q3 2011 · Sep 30, 2011 $175.01M
Operating Income Q3 2011 · Sep 30, 2010 $56.84M
Operating Income Q3 2011 · Sep 30, 2010 $124.6M
Revenue Q3 2011 · Sep 30, 2011 $415.4M
Revenue Q3 2011 · Sep 30, 2011 $1.21B
Revenue Q3 2011 · Sep 30, 2010 $365.38M
Revenue Q3 2011 · Sep 30, 2010 $1.08B